Cargando…

Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment

Our aims were to assess the spatiotemporal development of brain pathology in a mouse model of chronic hypoperfusion using magnetic resonance imaging (MRI), and to test whether the renin-angiotensin system (RAS) can offer therapeutic benefit. For the first time, different patterns of cerebral blood f...

Descripción completa

Detalles Bibliográficos
Autores principales: Füchtemeier, Martina, Brinckmann, Marie P, Foddis, Marco, Kunz, Alexander, Po, Chrystelle, Curato, Caterina, Dirnagl, Ulrich, Farr, Tracy D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348389/
https://www.ncbi.nlm.nih.gov/pubmed/25492118
http://dx.doi.org/10.1038/jcbfm.2014.221
_version_ 1782359910213746688
author Füchtemeier, Martina
Brinckmann, Marie P
Foddis, Marco
Kunz, Alexander
Po, Chrystelle
Curato, Caterina
Dirnagl, Ulrich
Farr, Tracy D
author_facet Füchtemeier, Martina
Brinckmann, Marie P
Foddis, Marco
Kunz, Alexander
Po, Chrystelle
Curato, Caterina
Dirnagl, Ulrich
Farr, Tracy D
author_sort Füchtemeier, Martina
collection PubMed
description Our aims were to assess the spatiotemporal development of brain pathology in a mouse model of chronic hypoperfusion using magnetic resonance imaging (MRI), and to test whether the renin-angiotensin system (RAS) can offer therapeutic benefit. For the first time, different patterns of cerebral blood flow alterations were observed in hypoperfused mice that ranged from an immediate and dramatic to a delayed decrease in cerebral perfusion. Diffusion tensor imaging revealed increases in several quantitative parameters in different brain regions that are indicative of white-matter degeneration; this began around 3 weeks after induction of hypoperfusion. While this model may be more variable than previously reported, neuroimaging tools represent a promising way to identify surrogate markers of pathology. Vascular remodelling was observed in hypoperfused mice, particularly in the anterior part of the Circle of Willis. While the angiotensin II receptor type 2 agonist, Compound 21 (C21), did not influence this response, it did promote expansion of the basilar artery in microcoil animals. Furthermore, C21-treated animals exhibited increased brain lymphocyte infiltration, and importantly, C21 had opposing effects on spatial reference memory in hypoperfused and sham mice. These results suggest that the RAS may have a role in vascular cognitive impairment.
format Online
Article
Text
id pubmed-4348389
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43483892015-03-16 Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment Füchtemeier, Martina Brinckmann, Marie P Foddis, Marco Kunz, Alexander Po, Chrystelle Curato, Caterina Dirnagl, Ulrich Farr, Tracy D J Cereb Blood Flow Metab Original Article Our aims were to assess the spatiotemporal development of brain pathology in a mouse model of chronic hypoperfusion using magnetic resonance imaging (MRI), and to test whether the renin-angiotensin system (RAS) can offer therapeutic benefit. For the first time, different patterns of cerebral blood flow alterations were observed in hypoperfused mice that ranged from an immediate and dramatic to a delayed decrease in cerebral perfusion. Diffusion tensor imaging revealed increases in several quantitative parameters in different brain regions that are indicative of white-matter degeneration; this began around 3 weeks after induction of hypoperfusion. While this model may be more variable than previously reported, neuroimaging tools represent a promising way to identify surrogate markers of pathology. Vascular remodelling was observed in hypoperfused mice, particularly in the anterior part of the Circle of Willis. While the angiotensin II receptor type 2 agonist, Compound 21 (C21), did not influence this response, it did promote expansion of the basilar artery in microcoil animals. Furthermore, C21-treated animals exhibited increased brain lymphocyte infiltration, and importantly, C21 had opposing effects on spatial reference memory in hypoperfused and sham mice. These results suggest that the RAS may have a role in vascular cognitive impairment. Nature Publishing Group 2015-03 2014-12-10 /pmc/articles/PMC4348389/ /pubmed/25492118 http://dx.doi.org/10.1038/jcbfm.2014.221 Text en Copyright © 2015 International Society for Cerebral Blood Flow & Metabolism, Inc. http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Original Article
Füchtemeier, Martina
Brinckmann, Marie P
Foddis, Marco
Kunz, Alexander
Po, Chrystelle
Curato, Caterina
Dirnagl, Ulrich
Farr, Tracy D
Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment
title Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment
title_full Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment
title_fullStr Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment
title_full_unstemmed Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment
title_short Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment
title_sort vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348389/
https://www.ncbi.nlm.nih.gov/pubmed/25492118
http://dx.doi.org/10.1038/jcbfm.2014.221
work_keys_str_mv AT fuchtemeiermartina vascularchangeandopposingeffectsoftheangiotensintype2receptorinamousemodelofvascularcognitiveimpairment
AT brinckmannmariep vascularchangeandopposingeffectsoftheangiotensintype2receptorinamousemodelofvascularcognitiveimpairment
AT foddismarco vascularchangeandopposingeffectsoftheangiotensintype2receptorinamousemodelofvascularcognitiveimpairment
AT kunzalexander vascularchangeandopposingeffectsoftheangiotensintype2receptorinamousemodelofvascularcognitiveimpairment
AT pochrystelle vascularchangeandopposingeffectsoftheangiotensintype2receptorinamousemodelofvascularcognitiveimpairment
AT curatocaterina vascularchangeandopposingeffectsoftheangiotensintype2receptorinamousemodelofvascularcognitiveimpairment
AT dirnaglulrich vascularchangeandopposingeffectsoftheangiotensintype2receptorinamousemodelofvascularcognitiveimpairment
AT farrtracyd vascularchangeandopposingeffectsoftheangiotensintype2receptorinamousemodelofvascularcognitiveimpairment